147 related articles for article (PubMed ID: 29707774)
1. Early-stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long-term patient outcomes.
Parsons SK; Kelly MJ; Cohen JT; Castellino SM; Henderson TO; Kelly KM; Keller FG; Henzer TJ; Kumar AJ; Johnson P; Meyer RM; Radford J; Raemaekers J; Hodgson DC; Evens AM
Br J Haematol; 2018 Jul; 182(2):212-221. PubMed ID: 29707774
[TBL] [Abstract][Full Text] [Related]
2. Informing radiotherapy decisions in stage I/IIa Hodgkin lymphoma: modeling life expectancy using radiation dosimetry.
Jones DA; Candio P; Shakir R; Ntentas G; Ramroth J; Gray AM; Cutter DJ
Blood Adv; 2022 Feb; 6(3):909-919. PubMed ID: 34872107
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy or Combined Modality Therapy for Early-stage Hodgkin Lymphoma.
Torok JA; Wu Y; Chino J; Prosnitz LR; Beaven AW; Kim GJ; Kelsey CR
Anticancer Res; 2018 May; 38(5):2875-2881. PubMed ID: 29715111
[TBL] [Abstract][Full Text] [Related]
4. Management of nodular lymphocyte predominant Hodgkin lymphoma in the modern era.
King MT; Donaldson SS; Link MP; Natkunam Y; Advani RH; Hoppe RT
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):67-75. PubMed ID: 25863755
[TBL] [Abstract][Full Text] [Related]
5. Hodgkin Lymphoma: the Changing Role of Radiation Therapy in Early-Stage Disease—the Role of Functional Imaging.
Iberri DJ; Hoppe RT; Advani RH
Curr Treat Options Oncol; 2015 Sep; 16(9):45. PubMed ID: 26187795
[TBL] [Abstract][Full Text] [Related]
6. Assessment of tumor size reduction improves outcome prediction of positron emission tomography/computed tomography after chemotherapy in advanced-stage Hodgkin lymphoma.
Kobe C; Kuhnert G; Kahraman D; Haverkamp H; Eich HT; Franke M; Persigehl T; Klutmann S; Amthauer H; Bockisch A; Kluge R; Wolf HH; Maintz D; Fuchs M; Borchmann P; Diehl V; Drzezga A; Engert A; Dietlein M
J Clin Oncol; 2014 Jun; 32(17):1776-81. PubMed ID: 24799482
[TBL] [Abstract][Full Text] [Related]
7. Combined modality therapy versus chemotherapy alone as an induction regimen for primary central nervous system lymphoma: a decision analysis.
Prica A; Chan K; Cheung MC
Br J Haematol; 2012 Sep; 158(5):600-7. PubMed ID: 22734565
[TBL] [Abstract][Full Text] [Related]
8. Stage IA-IIB Hodgkin's disease: management and outcome of extensive thoracic involvement.
Hughes-Davies L; Tarbell NJ; Coleman CN; Silver B; Shulman LN; Linggood R; Canellos GP; Mauch PM
Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):361-9. PubMed ID: 9308940
[TBL] [Abstract][Full Text] [Related]
9. Comparison of favorable early-stage hodgkin's lymphoma treatments: a single-institution review.
Samant R; Alomary I; Alsaeed E; Al-Jasir B; Bence-Bruckler I; Cross P; Genest P; Huebsch L
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1166-70. PubMed ID: 19695788
[TBL] [Abstract][Full Text] [Related]
10. Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications.
Koontz BF; Kirkpatrick JP; Clough RW; Prosnitz RG; Gockerman JP; Moore JO; Prosnitz LR
J Clin Oncol; 2006 Feb; 24(4):605-11. PubMed ID: 16446333
[TBL] [Abstract][Full Text] [Related]
11. Is combined modality therapy necessary for advanced Hodgkin's disease?
Mendenhall NP; Bennett CJ; Lynch JW
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):583-92. PubMed ID: 9231683
[TBL] [Abstract][Full Text] [Related]
12. Stage I-III Hodgkin's disease: outcome and pattern of failure following treatment with radiation therapy and chemotherapy in a modern era.
Zapatero A; López MA; Cerezo L; De Vidales CM; MarIn A; Pérez-Torrubia A
Hematology; 2002 Feb; 7(1):43-50. PubMed ID: 12171776
[TBL] [Abstract][Full Text] [Related]
13. Decision analysis on alternative treatment strategies for favorable-prognosis, early-stage Hodgkin's disease.
Ng AK; Weeks JC; Mauch PM; Kuntz KM
J Clin Oncol; 1999 Nov; 17(11):3577-85. PubMed ID: 10550157
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma.
Herbst C; Rehan FA; Skoetz N; Bohlius J; Brillant C; Schulz H; Monsef I; Specht L; Engert A
Cochrane Database Syst Rev; 2011 Feb; (2):CD007110. PubMed ID: 21328291
[TBL] [Abstract][Full Text] [Related]
15. Laparotomy versus no laparotomy in the management of early-stage, favorable-prognosis Hodgkin's disease: a decision analysis.
Ng AK; Weeks JC; Mauch PM; Kuntz KM
J Clin Oncol; 1999 Jan; 17(1):241-52. PubMed ID: 10458239
[TBL] [Abstract][Full Text] [Related]
16. Post-ABVD/pre-radiotherapy (18)F-FDG-PET provides additional prognostic information for early-stage Hodgkin lymphoma: a retrospective analysis on 165 patients.
Ciammella P; Filippi AR; Simontacchi G; Buglione M; Botto B; Mangoni M; Iotti C; Merli F; Marcheselli L; Bisi G; Ricardi U; Versari A
Br J Radiol; 2016; 89(1061):20150983. PubMed ID: 27022777
[TBL] [Abstract][Full Text] [Related]
17. [A analysis of the outcome and prognostic factors in 415 patients with Hodgkin lymphoma].
Tao Y; Kang S; Zhou L; Shi Y; Li Y; Sun Y
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):466-71. PubMed ID: 26463153
[TBL] [Abstract][Full Text] [Related]
18. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP
Borchmann P; Haverkamp H; Lohri A; Mey U; Kreissl S; Greil R; Markova J; Feuring-Buske M; Meissner J; Dührsen U; Ostermann H; Keller U; Maschmeyer G; Kuhnert G; Dietlein M; Kobe C; Eich H; Baues C; Stein H; Fuchs M; Diehl V; Engert A
Lancet Oncol; 2017 Apr; 18(4):454-463. PubMed ID: 28236583
[TBL] [Abstract][Full Text] [Related]
19. Hodgkin lymphoma: an Australian experience of ABVD chemotherapy in the modern era.
Jalali A; Ha FJ; Chong G; Grigg A; Mckendrick J; Schwarer AP; Doig R; Hamid A; Hawkes EA
Ann Hematol; 2016 Apr; 95(5):809-16. PubMed ID: 26878861
[TBL] [Abstract][Full Text] [Related]
20. Current approaches to the management of pediatric Hodgkin lymphoma.
Freed J; Kelly KM
Paediatr Drugs; 2010 Apr; 12(2):85-98. PubMed ID: 20218745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]